930 related articles for article (PubMed ID: 18330513)
1. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
5. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
Pfeiffer P
Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
8. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
[TBL] [Abstract][Full Text] [Related]
9. Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study.
Hildebrandt B; Wust P; Dräger J; Lüdemann L; Sreenivasa G; Tullius SG; Amthauer H; Neuhaus P; Felix R; Riess H
Int J Hyperthermia; 2004 Jun; 20(4):359-69. PubMed ID: 15204518
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
11. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
12. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
Tepper JE; O'Connell M; Hollis D; Niedzwiecki D; Cooke E; Mayer RJ;
J Clin Oncol; 2003 Oct; 21(19):3623-8. PubMed ID: 14512393
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation of locally recurrent nasopharyngeal carcinoma.
Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O
Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656
[TBL] [Abstract][Full Text] [Related]
14. [Therapy results of locoregional recurrences in rectal cancer].
Böhm B; Helfritzsch H; Thiele M; Altendorf-Hofmann A; Scheele J
Zentralbl Chir; 2001 Aug; 126(8):596-601. PubMed ID: 11518998
[TBL] [Abstract][Full Text] [Related]
15. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
[TBL] [Abstract][Full Text] [Related]
16. Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801).
Ngan SY; Fisher R; Burmeister BH; Mackay J; Goldstein D; Kneebone A; Schache D; Joseph D; McKendrick J; Leong T; McClure B; Rischin D
Dis Colon Rectum; 2005 Jul; 48(7):1389-96. PubMed ID: 15906126
[TBL] [Abstract][Full Text] [Related]
17. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
[TBL] [Abstract][Full Text] [Related]
18. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters.
Rau B; Wust P; Tilly W; Gellermann J; Harder C; Riess H; Budach V; Felix R; Schlag PM
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):381-91. PubMed ID: 10974451
[TBL] [Abstract][Full Text] [Related]
19. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
[TBL] [Abstract][Full Text] [Related]
20. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
Strnad V; Geiger M; Lotter M; Sauer R
Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]